Involvement of ERK and p38 MAPK pathways on interleukin-33-induced RANKL expression in osteoblastic cells

Cell Biology International

Volumn 38, Issue 5, 2014, Pages 655-662

  Mine, Yuichi ^a   Makihira, Seicho ^b   Yamaguchi, Yu ^a   Tanaka, Hideki ^a   Nikawa, Hiroki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Bone remodeling; Interleukin 33; MAPK; Osteoprotegerin; RANKL; ST2L

Indexed keywords

INTERLEUKIN 33; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE;

ANIMAL CELL; ARTICLE; BONE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; OPG GENE; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; RANKL GENE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DRUG EFFECTS; METABOLISM; OSTEOBLAST; PHYSIOLOGY;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANK LIGAND;

EID: 84899053326     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10249     Document Type: Article

References (32)

1. Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38.
2. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104: 282-7.
3. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M (2005) Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-akt-gata4 signaling pathway in cardiomyocytes. J Biol Chem 280: 4553-67.
4. Dai S M, Nishioka K, Yudoh K (2004) Interleukin (IL) 18 stimulates osteoclast formation through synovial t cells in rheumatoid arthritis: Comparison with IL1 beta and tumour necrosis factor alpha. Ann Rheum Dis 63: 1379-86.
5. Funakoshi-Tago M, Tago K, Hayakawa M, Tominaga S, Ohshio T, Sonoda Y, Kasahara T (2008) TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell Signal 20: 1679-86.
6. Hayakawa H, Hayakawa M, Kume A, Tominaga S (2007) Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282: 26369-80.
7. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S (1999) Interleukin-1beta and tumor necrosis factoralpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25: 255-9.
8. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y, Saito H, Galli SJ, Nakae S (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87: 971-8.
9. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-76.
10. Kulkarni RN, Bakker AD, Everts V, Klein-Nulend J (2012) Mechanical loading prevents the stimulating effect of IL-1b on osteocyte-modulated osteoclastogenesis. Biochem Biophys Res Commun 420: 11-6.
11. Lambert C, Oury C, Dejardin E, Chariot A, Piette J, Malaise M, Merville MP, Franchimont N (2007) Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. J Bone Miner Res 22: 1350-61.
12. Lerner UH (2004) New molecules in the tumor necrosis factor ligand and receptor superfamilies with importance for physiological and pathological bone resorption. Crit Rev Oral Biol Med 15: 64-81.
13. Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: The new kid in the IL-1 family. Nat Rev Immunol 10: 103-10.
14. Makiishi-Shimobayashi C, Tsujimura T, Iwasaki T, Yamada N, Sugihara A, Okamura H, Hayashi S, Terada N (2001) Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells. Biochem Biophys Res Commun 281: 361-6.
15. Miller AM (2011) Role of IL-33 in inflammation and disease. J Inflamm (Lond) 8: 22.
16. Mine Y, Makihira S, Nikawa H, Murata H, Hosokawa R, Hiyama A, Mimura S (2010) Impact of titaniumions on osteoblast-, osteoclastand gingival epithelial-like cells. J Prosthodont Res 54: 1-6.
17. Ohno T, Oboki K, Morita H, Kajiwara N, Arae K, Tanaka S, Ikeda M, Iikura M, Akiyama T, Inoue J, Matsumoto K, Sudo K, Azuma M, Okumura K, Kamradt T, Saito H, Nakae S (2011) Paracrine IL-33 stimulation enhances lipopolysaccharidemediated macrophage activation. PLoS One 6: e18404.
18. Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, Talabot-Ayer D, Gabay C, Smith DE (2008) The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble acp enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 42: 358-64.
19. Pantouli E, Boehm MM, Koka S (2005) Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells. Biochem Biophys Res Commun 329: 224-9.
20. Rossa C, Ehmann K, Liu M, Patil C, Kirkwood KL (2006) MKK3/ 6-p38 MAPK signaling is required for IL-1beta and TNFY alpha-induced RANKL expression in bone marrow stromal cells. J Interferon Cytokine Res 26: 719-29.
21. Saidi S, Bouri F, Lencel P, Duplomb L, Baud'huin M, Delplace S, Leterme D, Miellot F, Heymann D, Hardouin P, Palmer G, Magne D (2011) IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine 53: 347-54.
22. Saleh H, Eeles D, Hodge JM, Nicholson GC, Gu R, Pompolo S, Gillespie MT, Quinn JM (2011) Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology 152: 1911-22.
23. Schmitz J, Owyang A, OldhamE, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA, (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-90.
24. Schulze J, Bickert T, Beil FT, Zaiss MM, Albers J, Wintges K, Streichert T, Klaetschke K, Keller J, Hissnauer TN, Spiro AS, Gessner A, Schett G, Amling M, McKenzie AN, Horst AK, Schinke T (2011) Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res 26: 704-17.
25. Sharma S, Mahalingam CD, Das V, Jamal S, Levi E, Rishi AK, Datta. NS (2013) Cell cycle and apoptosis regulatory protein (CARP)-1 is expressed in osteoblasts and regulated by PTH. Biochem Biophys Res Commun 436: 607-12.
26. Smith DE (2011) The biological paths of IL-1 family members IL-18 and IL-33. J Leukoc Biol 89: 383-92.
27. Takami M, Cho ES, Lee SY, Kamijo R, Yim M (2005) Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: Possible involvement of ERK and p38 MAPK pathways. FEBS Lett 579: 832-8.
28. Takayanagi H (2007) Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292-304.
29. Thaler R, Zwerina J, Rumpler M, Spitzer S, Gamsjaeger S, Paschalis EP, Klaushofer K, Varga F (2013) Homocysteine induces serum amyloid A3 in osteoblasts via unlocking RGDmotifs in collagen. FASEB J 27: 446-63.
30. Xiong J, O'Brien CA (2012) Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res 27: 499-505.
31. Yndestad A, Marshall AK, Hodgkinson JD, Tham eL, Sugden PH, Clerk A (2010) Modulation of interleukin signalling and gene expression in cardiac myocytes by endothelin-1. Int J Biochem Cell Biol 42: 263-72.
32. Zhang W, Cong XL, Qin YH, He ZW, He DY, Dai SM (2013) IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 36: 103-9.